Colchicine Dosing and Monitoring in Renal Impairment

Introduction to Colchicine Therapy

• The risk of colchicine toxicity is very high in patients with decreased renal function, according to the European League Against Rheumatism 1, 2

Dosing Considerations

• Patients with renal impairment should not receive colchicine with strong P-glycoprotein and/or CYP3A4 inhibitors, as recommended by the American College of Rheumatology 3, 4

Alternative Therapies for Renal Impairment

• For acute gout flares in patients with severe renal impairment, consider corticosteroids or articular aspiration and injection of corticosteroids instead of colchicine, as suggested by the European League Against Rheumatism 3, 4
• For frequent flares in patients with contraindications to colchicine, NSAIDs, and corticosteroids, IL-1 blockers may be considered, according to the American College of Rheumatology 3, 1

Monitoring for Toxicity

• Signs of colchicine toxicity and creatinine phosphokinase (CPK) levels should be carefully monitored in patients with renal impairment, as recommended by the European League Against Rheumatism 2
• Statin co-administration requires additional monitoring due to increased risk of neurotoxicity and/or muscle toxicity, as suggested by the American Heart Association 5